The ala allele at val762ala polymorphism in poly(ADP-ribose) polymerase-1 (PARP-1) gene is associated with a decreased risk of asthma in a turkish population

Journal of Asthma

Volumn 46, Issue 4, 2009, Pages 371-374

  Tezcan, Gulcin ^a   Gurel, Cigdem Bayram ^a   Tutluoglu, Bulent ^a   Onaran, Ilhan ^a,b   Kanigur Sultuybek, Gonul ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Asthma; Genetic susceptibility; Poly(ADP ribose) polymerase 1; SNP

Indexed keywords

ALANINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; VALINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE);

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RISK REDUCTION; TURKEY (REPUBLIC); WILD TYPE; AGE DISTRIBUTION; ALLELE; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; INCIDENCE; METABOLISM; PROBABILITY; PROGNOSIS; REFERENCE VALUE; RISK; RISK ASSESSMENT; SEX RATIO;

AGE DISTRIBUTION; ALLELES; ANALYSIS OF VARIANCE; ASTHMA; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; ODDS RATIO; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TURKEY;

EID: 67649801536     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900902777791     Document Type: Article

References (30)

1. Bleecker ER, Postma DS, Meyers DA. Evidence for multiple genetic susceptibility loci for asthma. Am J Respir Crit Care Med 1997; 156:113-116.
2. Sandford A, Weir T, Pare P. The genetics of asthma. Am J Respir Crit Care Med 1996; 153:1749-1765.
3. Warrier MR, Hershey GK. Asthma genetics: personalizing medicine. J Asthma 2008; 45:257-264.
4. Liaudet L, Soriano FG, Szabo E, Virag L, Mabley JG, Salzman AL, Szabo C. Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase. Proc Natl Acad Sci USA 2000; 97:10203-10208.
5. García S, Bodaño A, Pablos JL, Gómez-Reino JJ, Conde C. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts. Ann Rheum Dis 2008; 67:631-637.
6. Szabó C, Dawson VL. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 1998; 19:287-298.
7. Boulares AH, Zoltoski AJ, Sherif ZA, Jolly P, Massaro D, Smulson ME. Gene knockout or pharmacological inhibition of poly(ADP-ribose) polymerase-1 prevents lung inflammation in a murine model of asthma. Am J Respir Cell Mol Biol 2003; 28:322-329.
8. Virág L, Bai P, Bak I, Pacher P, Mabley JG, Liaudet L, Bakondi E, Gergely P, Kollai M, Szabó C. Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma. Med Sci Monit 2004; 10:BR77-83.
9. Hassa PO, Covic M, Hasan S, Imhof R, Hottiger MO. The Enzymatic and DNA Binding Activity of PARP-1 are not required for NF-kappa B coactivator function. J Biol Chem 2001; 276:45588-45597.
10. Heeres JT, Hergenrother PJ. Poly(ADP-ribose) makes a date with death. Curr Opin Chem Biol 2007; 11:644-653.
11. Infante J, Llorca J, Mateo I, Rodríguez-Rodríguez E, Sánchez-Quintana C, Sánchez-Juan P, Fernández-Viadero C, Peña N, Berciano J, Combarros O. Interaction between poly(ADP-ribose) polymerase 1 and interleukin 1A genes is associated with Alzheimer's disease risk. Dement Geriatr Cogn Disord 2007; 23:215-218.
12. Oliver FJ, Ménissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, de la Rubia G, Stoclet JC, de Murcia G. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 1999; 18:4446-4454.
13. Cao WH, Wang X, Frappart L, Rigal D, Wang ZQ, Shen Y, Tong WM. Analysis of genetic variants of the poly(ADP-ribose) polymerase-1 gene in breast cancer in French patients. Mutat Res 2007; 632:20-28.
14. Cottet F, Blanche H, Verasdonck P, Le Gall I, Schächter F, Bürkle A, Muiras ML. New polymorphisms in the human poly (ADP-ribose) polymerase-1 coding sequence: lack of association with longevity or with increased cellular poly (ADP-ribosyl)ation capacity. J Mol Med 2000; 78: 471-480.
15. Mohrenweiser HW, Xi T, Vazquez-Matias J, Jones IM. Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol Biomark Prev 2002; 11:1054-1064.
16. Zhang Q, Li Y, Li X, Zhou W, Shi B, Chen H, Yuan W. PARP-1 Val762Ala polymorphism, CagA(+) H. pylori infection and risk for gastric cancer in Han Chinese population. Mol Biol Rep 2008; Aug 21. Epub Ahead off Print.
17. Nikitin AG, Chudakova DA, Strokov IA, Bursa TR, Chistiakov DA, Nosikov VV. Leu54Phe and Val762Ala polymorphisms in the poly(ADP-ribose)polymerase-1 gene are associated with diabetic polyneuropathy in Russian type 1 diabetic patients. Diabetes Res Clin Pract 2008; 79(3):446-452.
18. Stern MC, Conti DV, Siegmund KD, Corral R, Yuan JM, Koh WP, Yu MC. DNA repair single-nucleotide polymorphisms in colorectal cancer and their role as modifiers of the effect of cigarette smoking and alcohol in the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 2007; 16(11):2363-2372.
19. Infante J, Llorca J, Mateo I, Rodríguez-Rodríguez E, Sánchez-Quintana C, Sánchez-Juan P, Fernández-Viadero C, Peña N, Berciano J, Combarros O. Interaction between poly(ADP-ribose) polymerase 1 and interleukin 1A genes is associated with Alzheimer's disease risk. Dement Geriatr Cogn Disord 2007; 23(4):215-218.
20. Hur JW, Sung YK, Shin HD, Park BL, Cheong HS, Bae SC. Poly(ADP-ribose) polymerase (PARP) polymorphisms associated with nephritis and arthritis in systemic lupus erythematosus. Rheumatology (Oxford) 2006; 45(6):711-717.
21. Wang XG, Wang ZQ, Tong WM, Shen Y. PARP1 Val762Ala polymorphism reduces enzymatic activity. Biochem Biophys Res Commun 2007; 354:122-126.
22. Mathew CGP, The isolation of high molecular weight eukaryotic DNA. In: J. Walker, Editor, Methods of Molecular Biology vol. 2, Humana Press (1984), pp. 31-34.
23. Choi JE, Park SH, Jeon HS, Kim KM, Lee GY, Park RW, Kam S, Kim IS, Kim CH, Jheon SH, Jung TH, Park JY. No association between haplotypes of three variants (Codon 81, 284, and 762) in Poly (ADP-ribose) polymerase gene and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prevent 2003; 12:947-949.
24. Andreone TL, O'Connor M, Denenberg A, Hake PW, Zingarelli B. Poly(ADP-ribose) polymerase-1 regulates activation of activator protein-1 in murine fibroblasts. J Immunol 2003; 170:2113-2120.
25. Lockett KL, Hall MC, Xu J, Zheng SL, Berwick M, Chuang SC, Clark PE, Cramer SD, Lohman K, Hu JJ. The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res 2004; 64:6344-6348.
26. Onaran I, Tezcan G, Özgönenel L, Çetin E, Özdemir AT, Sultuybek GK. The Val762Ala polymorphism in the poly (ADP-ribose) polymerase-1 gene is not associated with susceptibility in Turkish rheumatoid arthritis patients. Rheumatol Int 2008 Nov 22. [Epub ahead of print].
27. Virág L. Poly(ADP-ribosyl)ation in asthma and other lung diseases. Pharmacol Res 2005; 52:83-92.
28. Ferwerda B, McCall MB, Alonso S, Giamarellos-Bourboulis EJ, Mouk-taroudi M, Izagirre N, Syafruddin D, Kibiki G, Cristea T, Hijmans A, Hamann L, Israel S, ElGhazali G, Troye-Blomberg M, Kumpf O, Maiga B, Dolo A, Doumbo O, Hermsen CC, Stalenhoef AF, van Crevel R, Brunner HG, Oh DY, Schumann RR, de la Rúa C, Sauerwein R, Kullberg BJ, van der Ven AJ, van der Meer JW, Netea MG. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci USA 2007; 16;104(42):16645-16650.
29. Schröder NW, Diterich I, Zinke A, Eckert J, Draing C, von Baehr V, Hassler D, Priem S, Hahn K, Michelsen KS, Hartung T, Burmester GR, Göbel UB, Hermann C, Schumann RR. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol 2005; 175(4):2534-2540.
30. Suzuki Y, Masini E, Mazzocca C, Cuzzocrea S, Ciampa A, Suzuki H, Bani D. Inhibition of poly(ADP-ribose) polymerase prevents allergen-induced asthma-like reaction in sensitized Guinea pigs. J Pharmacol Exp Ther 2004; 311:1241-1448.